The global facial rejuvenation market is estimated to value over $25.10 billion by the end of 2026 and is projected to register a CAGR of 4.9% during the forecast period 2018 to 2026. The cosmetic treatments that require minimally invasive procedures are gaining popularity, thus resulting in the proliferation of the facial rejuvenation market. There is a growing demand for aesthetic treatment, especially from the female patient population, which has further augmented the market significantly. 

Several cosmetic companies are taking efforts in expanding their market by introducing advanced treatments for nasal folds, forehead lines, glabellar lines, and wrinkles, through products like botulinum and dermal fillers which, have boosted the market growth further. 

The FDA has approved absorbable dermal fillers for cheek and lip augmentation and contour deficiencies in patients over the age of 21, which shall prove instrumental for the market to grow significantly. 

The botulinum toxin segment accounts for around one-third of the total facial rejuvenation treatment revenue share, owing to its high usage, especially among models and celebrities who need to keep their skin tight to look young. Furthermore, portable, laser-based devices integrated with topical skin care products have witnessed increased adoption, which has boosted the market growth further.

The hospital segment accounts for the highest market share, owing to the premium quality of infrastructure that hospitals offer. Additionally, with the introduction of multispecialty hospitals, the acquisition of the patient population has significantly increased, assisting the facial rejuvenation market to thrive. 

However, emerging economies like India and China have a majority of the population in the lower-middle-class category that cannot afford before-mentioned high expenditures, which is why dermatology clinics are preferred for facial rejuvenation treatments in these countries.